{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:18:42Z","timestamp":1782310722660,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40272-016-0203-3","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T11:39:22Z","timestamp":1478605162000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study"],"prefix":"10.1007","volume":"19","author":[{"given":"Hese","family":"Cosar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih Cagr\u0131","family":"Cak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nese","family":"Yar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Goksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Tokbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Kertmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikbal","family":"Durak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"key":"203_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0022-3476(05)80963-1","volume":"123","author":"TN Raju","year":"1993","unstructured":"Raju TN, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr. 1993;123:603\u201310.","journal-title":"J Pediatr"},{"key":"203_CR2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1651-2227.2009.01551.x","volume":"99","author":"C Poralla","year":"2010","unstructured":"Poralla C, Hertfelder HJ, Oldenburg J, et al. Treatment of acute pulmonary haemorrhage in extremely preterm infants with recombinant activated factor VII. Acta Paediatr. 2010;99:298\u2013300.","journal-title":"Acta Paediatr"},{"key":"203_CR3","doi-asserted-by":"publisher","first-page":"F40","DOI":"10.1136\/fn.81.1.F40","volume":"81","author":"PB Pandit","year":"1999","unstructured":"Pandit PB, O\u2019Brien K, Asztalos E, Colucci E, Dunn MS. Outcome following pulmonary hemorrhage in very low birthweight neonates treated with surfactant. Arch Dis Child Fetal Neonatal Ed. 1999;81:F40\u20134.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"203_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/sj.jp.7210787","volume":"22","author":"N Olomu","year":"2002","unstructured":"Olomu N, Kulkarni R, Manco-Johnson M. Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. J Perinatol. 2002;22:672\u20134.","journal-title":"J Perinatol"},{"key":"203_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archpedi.153.7.715","volume":"153","author":"M Tomaszewska","year":"1999","unstructured":"Tomaszewska M, Stork E, Minich NM, Friedman H, Berlin S, Hack M. Pulmonary hemorrhage: clinical course and outcomes among very lowbirth-weight infants. Arch Pediatr Adolesc Med. 1999;153:715\u201321.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"203_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1067\/mpd.2000.106569","volume":"137","author":"M Kluckow","year":"2000","unstructured":"Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr. 2000;137:68\u201372.","journal-title":"J Pediatr"},{"key":"203_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/adc.50.2.123","volume":"50","author":"R Trompeter","year":"1975","unstructured":"Trompeter R, Yu VU, Ansley-Green A, Roberton NR. Massive pulmonary hemorrhage in the newborn infant. Arch Dis Child. 1975;50:123\u20137.","journal-title":"Arch Dis Child"},{"issue":"6","key":"203_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/clpt.1994.80","volume":"55","author":"CM Lindley","year":"1994","unstructured":"Lindley CM, et al. Pharmacokinetics and pharmacodynamics of recombinant Factor VIIa. Clin Pharmacol Ther. 1994;55(6):638\u201348.","journal-title":"Clin Pharmacol Ther"},{"key":"203_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/jp.2010.85","volume":"31","author":"CN Dang","year":"2011","unstructured":"Dang CN, Katakam LI, Smith PB, et al. Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. J Perinatol. 2011;31:188\u201392.","journal-title":"J Perinatol"},{"key":"203_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1440-1754.2006.00867.x","volume":"42","author":"JD Robertson","year":"2006","unstructured":"Robertson JD. Prevention of intraventricular haemorrhage: a role for recombinant activated factor VII? J Paediatr Child Health. 2006;42:325\u201331.","journal-title":"J Paediatr Child Health"},{"issue":"13\u201314","key":"203_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10354-008-0538-7","volume":"158","author":"E Pichler","year":"2008","unstructured":"Pichler E, Pichler L. The neonatal coagulation system and the vitamin K deficiency bleeding\u2014a mini review. Wien Med Wochenschr. 2008;158(13\u201314):385\u201395.","journal-title":"Wien Med Wochenschr"},{"key":"203_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/01.PCC.0000185491.17584.4B","volume":"7","author":"A Veldman","year":"2006","unstructured":"Veldman A, Josef J, Fischer D, Volk WR. A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 hours of life. Pediatr Crit Care Med. 2006;7:34\u20139.","journal-title":"Pediatr Crit Care Med"},{"key":"203_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MPH.0b013e3180335bcb","volume":"29","author":"G Mitsiakos","year":"2007","unstructured":"Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N. Is the use of rFVIIa safe and effective in bleeding neonates? J Pediatr Hematol Oncol. 2007;29:145\u201350.","journal-title":"J Pediatr Hematol Oncol"},{"key":"203_CR14","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1460-9592.2006.02039.x","volume":"16","author":"KM Brady","year":"2006","unstructured":"Brady KM, Easley RB, Tobias JD. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Pediatr Anesth. 2006;16:1042\u20136.","journal-title":"Pediatr Anesth"},{"key":"203_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/01.mbc.0000220245.20036.2d","volume":"17","author":"H Cetin","year":"2006","unstructured":"Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Blood Coagul Fibrinolysis. 2006;17:213\u20136.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"203_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MPH.0b013e318286d27e","volume":"35","author":"E Gkiougki","year":"2013","unstructured":"Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N. Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. J Pediatr Hematol Oncol. 2013;35:221\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"203_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jpeds.2005.07.034","volume":"147","author":"PM Filan","year":"2005","unstructured":"Filan PM, Mills JF, Clarnette TD, et al. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa. J Pediatr. 2005;147:857\u20139.","journal-title":"J Pediatr"},{"key":"203_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/sj.jp.7211588","volume":"26","author":"C Hunseler","year":"2006","unstructured":"Hunseler C, Kribs A, Eifinger F, et al. Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature. J Perinatol. 2006;26:706\u201313.","journal-title":"J Perinatol"},{"key":"203_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MPH.0b013e3181639b28","volume":"30","author":"D Fischer","year":"2008","unstructured":"Fischer D, Schloesser R, Buxmann H, et al. Recombinant activated factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation. J Pediatr Hematol Oncol. 2008;30:337\u201342.","journal-title":"J Pediatr Hematol Oncol"},{"key":"203_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MBC.0b013e32832f6c40","volume":"20","author":"K Faust","year":"2009","unstructured":"Faust K, Troger B, Kahl F, et al. Successful use of recombinant factor VIIa in a preterm infant with life-threatening haematuria. Blood Coagul Fibrinolysis. 2009;20:601\u20134.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"203_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00001721-200301000-00021","volume":"14","author":"G Greisen","year":"2003","unstructured":"Greisen G, Andreasen RB. Recombinant factor VIIa in preterm neonates with prolonged prothrombin time. Blood Coagul Fibrinolysis. 2003;14:117\u201320.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"203_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","journal-title":"Arch Ophthalmol"},{"key":"203_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"MJ Bell","year":"1978","unstructured":"Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1\u20137.","journal-title":"Ann Surg"},{"key":"203_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 g. J Pediatr. 1978;92:529\u201334.","journal-title":"J Pediatr"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-016-0203-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:03:57Z","timestamp":1744715037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-016-0203-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1007\/s40272-016-0203-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]},"assertion":[{"value":"8 November 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Hese Cosar, Halil Isik, Salih Cagr\u0131 Cak\u0131r, Nese Yar, Bulent Goksen, Hakan Tokbay, Hasan Kertmen, Nihal Erdo\u011fan, and Ikbal Durak declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}